The Lancet Oncology 今日热榜



The Lancet Oncology The Lancet Oncology

1.	[Clinical Picture] IVLBCL mimicking VEXAS syndrome	Kevin Shopsowitz, Alym Abdulla, Habib Moshref Razavi	
2.	[Editorial] Reviving the UK NHS: Labour's biggest challenge?	The Lancet Oncology	
3.	[Review] Development of a conceptual framework for an electronic patient-reported outcome (ePRO) system measuring symptoms and impacts of CAR T-cell therapies in patients with haematological malignancies	Foram Khatsuria, Christel McMullan, Olalekan Lee Aiyegbusi, Karen L Shaw, Roshina Iqbal, Francesca Kinsella, Keith Wilson, Lester Pyatt, Marlene Lewis, Sophie M R Wheldon, David Burns, Ronjon Chakraverty, Melanie Calvert, Sarah E Hughes	
4.	[Articles] Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial	Eunice S Wang, Ghayas C Issa, Harry P Erba, Jessica K Altman, Pau Montesinos, Stephane DeBotton, Roland B Walter, Kristen Pettit, Michael R Savona, Mithun Vinod Shah, Marina Kremyanskaya, Maria R Baer, James M Foran, Gary Schiller, Lionel Adès, Mael Heiblig, Celine Berthon, Pierre Peterlin, Eduardo Rodríguez-Arbolí, Olga Salamero, Mrinal M Patnaik, Cristina Papayannidis, Jolanta Grembecka, Tomasz Cierpicki, Bradley Clegg, Joshua Ray, Brian M Linhares, Kun Nie, Amitava Mitra, Julie Mackey Ahsan, Marilyn Tabachri, Harris S Soifer, Daniel Corum, Mollie Leoni, Stephen Dale, Amir T Fathi	
5.	[Policy Review] Challenges and opportunities for early phase clinical trials of novel drug–radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO)	Zachary S Zumsteg, Siddharth Sheth, Salma K Jabbour, Krishnan R Patel, Randall J Kimple, Terence M Williams, Meng Xu-Welliver, Pedro A Torres-Saavedra, Arta M Monjazeb, Jyoti Mayadev, Steven E Finkelstein, John M Buatti, Sandip P Patel, Steven H Lin	
6.	[Perspectives] Using cancer to fuel art at the Edinburgh Festival Fringe	Peter Ranscombe	
7.	[Corrections] Correction to Lancet Oncol 2024; 25: 989–1002		
8.	[Perspectives] The Cancer Tapestry is telling a thousand stories	Peter Ranscombe	
9.	[Comment] Precision medicine with MET exon 14: a partial success	Quincy S-C Chu	
10.	[Correspondence] Adverse obstetric outcomes in female survivors of adolescent and young adult cancers	Yizhuan Huang, Han Wang	
11.	[Correspondence] Adverse obstetric outcomes in female survivors of adolescentand young adult cancers – Authors' reply	Raoul C Reulen, Ceren Sunguc, David L Winter, Gavin Rudge, Angela Polanco, Katherine A Birchenall, Melanie Griffin, W Hamish B Wallace, Richard A Anderson, Michael M Hawkins	
12.	[Correspondence] Adverse obstetric outcomes in female survivors of adolescent and young adult cancers	Weizhen Tang, Taihang Liu, Xia Lan	
13.	[Correspondence] Adverse obstetric outcomes in female survivors of adolescent and young adult cancers	Ying Cui	
14.	[Personal View] A brave new framework for glioma drug development	Kelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, Marjolein Geurts, Timothy F Cloughesy, Jason Huse, Elizabeth S Duke, Justin Lathia, David M Ashley, Edjah K Nduom, Georgina Long, Kirit Singh, Anthony Chalmers, Manmeet S Ahluwalia, Amy Heimberger, Stephen Bagley, Tomoki Todo, Roel Verhaak, Patrick D Kelly, Shawn Hervey-Jumper, John de Groot, Anoop Patel, Peter Fecci, Ian Parney, Victoria Wykes, Colin Watts, Terry C Burns, Nader Sanai, Matthias Preusser, Joerg Christian Tonn, Katharine J Drummond, Michael Platten, Sunit Das, Kirk Tanner, Michael A Vogelbaum, Michael Weller, James R Whittle, Mitchel S Berger, Mustafa Khasraw	
15.	[Personal View] The tyranny of non-inferiority trials	Ian F Tannock, Marc Buyse, Mickael De Backer, Helena Earl, Daniel A Goldstein, Mark J Ratain, Leonard B Saltz, Gabe S Sonke, Garth W Strohbehn	
16.	[Comment] Diagnostic accuracy of risk prediction models in postmenopausal patients with suspected ovarian cancer	Cagatay Taskiran, Muhterem Melis Canturk	
17.	[Articles] Risk-prediction models in postmenopausal patients with symptoms of suspected ovarian cancer in the UK (ROCkeTS): a multicentre, prospective diagnostic accuracy study	Sudha Sundar, Ridhi Agarwal, Clare Davenport, Katie Scandrett, Susanne Johnson, Partha Sengupta, Radhika Selvi-Vikram, Fong Lien Kwong, Sue Mallett, Caroline Rick, Sean Kehoe, Dirk Timmerman, Tom Bourne, Ben Van Calster, Hilary Stobart, Richard D Neal, Usha Menon, Alex Gentry-Maharaj, Lauren Sturdy, Ryan Ottridge, Jon Deeks, ROCkeTS collaborators	
18.	[Correspondence] Investigating hidden influences on treatment for gastrointestinal stromal tumours with AI: diet, chronic conditions, and mental health	Hanjun Ma, Shibo Zhao, Mingxuan Liu, Qunqiang Luo	
19.	[Articles] Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial	Jürgen Wolf, Maximilian Hochmair, Ji-Youn Han, Noemi Reguart, Pierre-Jean Souquet, Egbert F Smit, Sergey V Orlov, Johan Vansteenkiste, Makoto Nishio, Maja de Jonge, Wallace Akerley, Edward B Garon, Harry J M Groen, Daniel S W Tan, Takashi Seto, Garrett M Frampton, Anna Robeva, Mariana Carbini, Sylvie Le Mouhaer, Alejandro Yovine, Aislyn Boran, Claudia Bossen, Yiqun Yang, Lexiang Ji, Lauren Fairchild, Rebecca S Heist	
20.	[Correspondence] Investigating hidden influences on treatment for gastrointestinal stromal tumours with AI: diet, chronic conditions, and mental health – Authors' reply	Georgios Antonios Margonis, Dimitris Bersimas, Samuel Singer	
21.	[Comment] A step closer to the use of [177Lu]Lu-PSMA-617 in metastatic hormone-sensitive prostate cancer	Angela Y Jia, Daniel E Spratt	
22.	[Correspondence] NHS cancer services and systems: critical support for cancer care	David Stewart Morrison, Kathryn Puxty	
23.	[Perspectives] Losing my brother, finding myself	Jules Morgan	
24.	[Personal View] Best practices and novel approaches for the preclinical development of drug–radiotherapy combinations for cancer treatment	Pataje G S Prasanna, Mansoor M Ahmed, Julie A Hong, C Norman Coleman	
25.	[News] Families of cancer victims wait for benefits decades after the World Trade Center attack	Karl Gruber	
26.	[News] ESMO Congress 2024	Cheryl Lai	
27.	[Articles] Sequential [177Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study	Arun A Azad, Mathias Bressel, Hsiang Tan, Mark Voskoboynik, Aneta Suder, Andrew J Weickhardt, Alexander Guminski, Roslyn J Francis, Javad Saghebi, Nattakorn Dhiantravan, Anthony M Joshua, Louise Emmett, Lisa Horvath, Declan G Murphy, Edward Hsiao, Bavanthi Balakrishnar, Peter Lin, Andrew Redfern, William Macdonald, Siobhan Ng, Sze-Ting Lee, David A Pattison, David Nadebaum, Ian D Kirkwood, Michael S Hofman, UpFrontPSMA Study Team	
28.	[Articles] Belzutifan for patients with von Hippel-Lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 study	Othon Iliopoulos, Ane B Iversen, Vivek Narayan, Benjamin L Maughan, Kathryn E Beckermann, Stephane Oudard, Tobias Else, Jodi K Maranchie, Cynthia Muller Goldberg, Wei Fu, Rodolfo F Perini, Yanfang Liu, W Marston Linehan, Ramaprasad Srinivasan, Eric Jonasch	
29.	[News] Petition to end travel insurance discrimination against people with cancer	Manjulika Das	
30.	[News] Rising costs of cancer medicines	Sharmila Devi	
31.	[Articles] Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial	Zikun Peng, Huayi Li, Yunong Gao, Li Sun, Jie Jiang, Bairong Xia, Yi Huang, Yu Zhang, Yu Xia, Yuxin Zhang, Yiyang Shen, Bowen Huang, Jiayu Nie, Xinrong Chen, Xingyu Liu, Cui Feng, Zhen Li, Wei Zhang, Kangjia Tao, Qiuxue Zhang, Shican Duan, Yaheng Chen, Yeshan Chen, Wei Wang, Hong Zheng, Yudong Lu, Yi Liu, Limei Wang, Wencai Qi, Yang He, Yan Tian, NUWA Platform Research Group, Guiling Li, Ding Ma, Qinglei Gao	
32.	[Comment] Treatment of Richter transformation—immunotherapy to the rescue?	Othman Al-Sawaf, Barbara Eichhorst	
33.	[Articles] [89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial	Brian Shuch, Allan J Pantuck, Jean-Christophe Bernhard, Michael A Morris, Viraj Master, Andrew M Scott, Charles van Praet, Clement Bailly, Bülent Önal, Tamer Aksoy, Robin Merkx, David M Schuster, Sze Ting Lee, Neeta Pandit-Taskar, Alice C Fan, Phillip Allman, Karl Schmidt, Libuse Tauchmanova, Michael Wheatcroft, Christian Behrenbruch, Colin R W Hayward, Peter Mulders	
34.	[Articles] Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial	Alessandra Tedeschi, Anna Maria Frustaci, Adalgisa Condoluci, Marta Coscia, Roberto Chiarle, Pier Luigi Zinzani, Marina Motta, Gianluca Gaidano, Giulia Quaresmini, Lydia Scarfò, Gioacchino Catania, Marina Deodato, Rebecca Jones, Valentina Tabanelli, Valentina Griggio, Georg Stüssi, Angelica Calleri, Katia Pini, Roberto Cairoli, Thorsten Zenz, Alessio Signori, Emanuele Zucca, Davide Rossi, Marco Montillo	
35.	[News] New developments in tobacco control measures in Europe	Talha Burki	
36.	[News] European Commission approval for Dutch investment in radiopharmaceuticals	Karl Gruber	
37.	[Articles] Palliative radiotherapy versus best supportive care in patients with painful hepatic cancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 study	Laura A Dawson, Jolie Ringash, Alysa Fairchild, Paul Stos, Kristopher Dennis, Aamer Mahmud, Teri Lynn Stuckless, Francois Vincent, David Roberge, Matthew Follwell, Raimond K W Wong, Derek J Jonker, Jennifer J Knox, Camilla Zimmermann, Philip Wong, Aisling S Barry, Marc Gaudet, Rebecca K S Wong, Thomas G Purdie, Dongsheng Tu, Christopher J O'Callaghan	
38.	[Comment] Radiation oncology: a call for papers for ESTRO 2025	David Collingridge, Pierre Blanchard	
39.	[News] Continued suboptimal HPV vaccine coverage in the USA	Talha Burki	
40.	[News] World's first lung cancer vaccine trial launched in the UK	Elizabeth Gourd	
41.	[News] Medicare drug price negotiations by the US Government	Sharmila Devi	
42.	[Comment] The UK needs to be a leader, not a lagger, in the global cancer effort	Mark Lawler, Ajay Aggarwal, Julie Gralow, Richard Sullivan, Pat Price	
43.	[Articles] Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis	Yi Zhao, Ying He, Wei Wang, Qi Cai, Fan Ge, Zisheng Chen, Jianqi Zheng, Yuan Zhang, Hongsheng Deng, Ying Chen, Shen Lao, Hengrui Liang, Wenhua Liang, Jianxing He	

更新于 3 分钟前

近期历史最近 100 条记录

2024-10-01	[Clinical Picture] IVLBCL mimicking VEXAS syndrome	Kevin Shopsowitz, Alym Abdulla, Habib Moshref Razavi	
2024-10-01	[Editorial] Reviving the UK NHS: Labour's biggest challenge?	The Lancet Oncology	
2024-10-01	[Review] Development of a conceptual framework for an electronic patient-reported outcome (ePRO) system measuring symptoms and impacts of CAR T-cell therapies in patients with haematological malignancies	Foram Khatsuria, Christel McMullan, Olalekan Lee Aiyegbusi, Karen L Shaw, Roshina Iqbal, Francesca Kinsella, Keith Wilson, Lester Pyatt, Marlene Lewis, Sophie M R Wheldon, David Burns, Ronjon Chakraverty, Melanie Calvert, Sarah E Hughes	
2024-10-01	[Articles] Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial	Eunice S Wang, Ghayas C Issa, Harry P Erba, Jessica K Altman, Pau Montesinos, Stephane DeBotton, Roland B Walter, Kristen Pettit, Michael R Savona, Mithun Vinod Shah, Marina Kremyanskaya, Maria R Baer, James M Foran, Gary Schiller, Lionel Adès, Mael Heibl	
2024-10-01	[Policy Review] Challenges and opportunities for early phase clinical trials of novel drug–radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sara	Zachary S Zumsteg, Siddharth Sheth, Salma K Jabbour, Krishnan R Patel, Randall J Kimple, Terence M Williams, Meng Xu-Welliver, Pedro A Torres-Saavedra, Arta M Monjazeb, Jyoti Mayadev, Steven E Finkelstein, John M Buatti, Sandip P Patel, Steven H Lin	
2024-10-01	[Perspectives] Using cancer to fuel art at the Edinburgh Festival Fringe	Peter Ranscombe	
2024-10-01	[Corrections] Correction to Lancet Oncol 2024; 25: 989–1002		
2024-10-01	[Perspectives] The Cancer Tapestry is telling a thousand stories	Peter Ranscombe	
2024-10-01	[Comment] Precision medicine with MET exon 14: a partial success	Quincy S-C Chu	
2024-10-01	[Correspondence] Adverse obstetric outcomes in female survivors of adolescent and young adult cancers	Yizhuan Huang, Han Wang	
2024-10-01	[Correspondence] Adverse obstetric outcomes in female survivors of adolescentand young adult cancers – Authors' reply	Raoul C Reulen, Ceren Sunguc, David L Winter, Gavin Rudge, Angela Polanco, Katherine A Birchenall, Melanie Griffin, W Hamish B Wallace, Richard A Anderson, Michael M Hawkins	
2024-10-01	[Correspondence] Adverse obstetric outcomes in female survivors of adolescent and young adult cancers	Weizhen Tang, Taihang Liu, Xia Lan	
2024-10-01	[Correspondence] Adverse obstetric outcomes in female survivors of adolescent and young adult cancers	Ying Cui	
2024-10-01	[Personal View] A brave new framework for glioma drug development	Kelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, Marjolein Geurts, Timothy F Cloughesy, Jason Huse, Elizabeth S Duke, Justin Lathia, David M Ashley, Edjah K Nduom, Georgina Long, Kirit Singh, Anthony Chalmers, Manmeet S Ahluwalia, Amy Heimberger, S	
2024-10-01	[Personal View] The tyranny of non-inferiority trials	Ian F Tannock, Marc Buyse, Mickael De Backer, Helena Earl, Daniel A Goldstein, Mark J Ratain, Leonard B Saltz, Gabe S Sonke, Garth W Strohbehn	
2024-10-01	[Comment] Diagnostic accuracy of risk prediction models in postmenopausal patients with suspected ovarian cancer	Cagatay Taskiran, Muhterem Melis Canturk	
2024-10-01	[Articles] Risk-prediction models in postmenopausal patients with symptoms of suspected ovarian cancer in the UK (ROCkeTS): a multicentre, prospective diagnostic accuracy study	Sudha Sundar, Ridhi Agarwal, Clare Davenport, Katie Scandrett, Susanne Johnson, Partha Sengupta, Radhika Selvi-Vikram, Fong Lien Kwong, Sue Mallett, Caroline Rick, Sean Kehoe, Dirk Timmerman, Tom Bourne, Ben Van Calster, Hilary Stobart, Richard D Neal, Us	
2024-10-01	[Correspondence] Investigating hidden influences on treatment for gastrointestinal stromal tumours with AI: diet, chronic conditions, and mental health	Hanjun Ma, Shibo Zhao, Mingxuan Liu, Qunqiang Luo	
2024-10-01	[Articles] Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial	Jürgen Wolf, Maximilian Hochmair, Ji-Youn Han, Noemi Reguart, Pierre-Jean Souquet, Egbert F Smit, Sergey V Orlov, Johan Vansteenkiste, Makoto Nishio, Maja de Jonge, Wallace Akerley, Edward B Garon, Harry J M Groen, Daniel S W Tan, Takashi Seto, Garrett M	
2024-10-01	[Correspondence] Investigating hidden influences on treatment for gastrointestinal stromal tumours with AI: diet, chronic conditions, and mental health – Authors' reply	Georgios Antonios Margonis, Dimitris Bersimas, Samuel Singer	
2024-10-01	[Comment] A step closer to the use of [177Lu]Lu-PSMA-617 in metastatic hormone-sensitive prostate cancer	Angela Y Jia, Daniel E Spratt	
2024-10-01	[Correspondence] NHS cancer services and systems: critical support for cancer care	David Stewart Morrison, Kathryn Puxty	
2024-10-01	[Perspectives] Losing my brother, finding myself	Jules Morgan	
2024-10-01	[Personal View] Best practices and novel approaches for the preclinical development of drug–radiotherapy combinations for cancer treatment	Pataje G S Prasanna, Mansoor M Ahmed, Julie A Hong, C Norman Coleman	
2024-10-01	[News] Families of cancer victims wait for benefits decades after the World Trade Center attack	Karl Gruber	
2024-10-01	[News] ESMO Congress 2024	Cheryl Lai	
2024-10-01	[Articles] Sequential [177Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study	Arun A Azad, Mathias Bressel, Hsiang Tan, Mark Voskoboynik, Aneta Suder, Andrew J Weickhardt, Alexander Guminski, Roslyn J Francis, Javad Saghebi, Nattakorn Dhiantravan, Anthony M Joshua, Louise Emmett, Lisa Horvath, Declan G Murphy, Edward Hsiao, Bavanth	
2024-10-01	[Articles] Belzutifan for patients with von Hippel-Lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 study	Othon Iliopoulos, Ane B Iversen, Vivek Narayan, Benjamin L Maughan, Kathryn E Beckermann, Stephane Oudard, Tobias Else, Jodi K Maranchie, Cynthia Muller Goldberg, Wei Fu, Rodolfo F Perini, Yanfang Liu, W Marston Linehan, Ramaprasad Srinivasan, Eric Jonasc	
2024-10-01	[News] Petition to end travel insurance discrimination against people with cancer	Manjulika Das	
2024-10-01	[News] Rising costs of cancer medicines	Sharmila Devi	
2024-10-01	[Articles] Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial	Zikun Peng, Huayi Li, Yunong Gao, Li Sun, Jie Jiang, Bairong Xia, Yi Huang, Yu Zhang, Yu Xia, Yuxin Zhang, Yiyang Shen, Bowen Huang, Jiayu Nie, Xinrong Chen, Xingyu Liu, Cui Feng, Zhen Li, Wei Zhang, Kangjia Tao, Qiuxue Zhang, Shican Duan, Yaheng Chen, Ye	
2024-10-01	[Articles] Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial	Alessandra Tedeschi, Anna Maria Frustaci, Adalgisa Condoluci, Marta Coscia, Roberto Chiarle, Pier Luigi Zinzani, Marina Motta, Gianluca Gaidano, Giulia Quaresmini, Lydia Scarfò, Gioacchino Catania, Marina Deodato, Rebecca Jones, Valentina Tabanelli, Valen	
2024-10-01	[Articles] [89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial	Brian Shuch, Allan J Pantuck, Jean-Christophe Bernhard, Michael A Morris, Viraj Master, Andrew M Scott, Charles van Praet, Clement Bailly, Bülent Önal, Tamer Aksoy, Robin Merkx, David M Schuster, Sze Ting Lee, Neeta Pandit-Taskar, Alice C Fan, Phillip All	
2024-10-01	[Comment] Treatment of Richter transformation—immunotherapy to the rescue?	Othman Al-Sawaf, Barbara Eichhorst	
2024-10-01	[Articles] Palliative radiotherapy versus best supportive care in patients with painful hepatic cancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 study	Laura A Dawson, Jolie Ringash, Alysa Fairchild, Paul Stos, Kristopher Dennis, Aamer Mahmud, Teri Lynn Stuckless, Francois Vincent, David Roberge, Matthew Follwell, Raimond K W Wong, Derek J Jonker, Jennifer J Knox, Camilla Zimmermann, Philip Wong, Aisling	
2024-10-01	[News] New developments in tobacco control measures in Europe	Talha Burki	
2024-10-01	[News] European Commission approval for Dutch investment in radiopharmaceuticals	Karl Gruber	
2024-10-01	[Comment] Radiation oncology: a call for papers for ESTRO 2025	David Collingridge, Pierre Blanchard	
2024-10-01	[News] World's first lung cancer vaccine trial launched in the UK	Elizabeth Gourd	
2024-10-01	[News] Continued suboptimal HPV vaccine coverage in the USA	Talha Burki	
2024-10-01	[News] Medicare drug price negotiations by the US Government	Sharmila Devi	
2024-10-01	[Comment] The UK needs to be a leader, not a lagger, in the global cancer effort	Mark Lawler, Ajay Aggarwal, Julie Gralow, Richard Sullivan, Pat Price	
2024-10-01	[Articles] Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis	Yi Zhao, Ying He, Wei Wang, Qi Cai, Fan Ge, Zisheng Chen, Jianqi Zheng, Yuan Zhang, Hongsheng Deng, Ying Chen, Shen Lao, Hengrui Liang, Wenhua Liang, Jianxing He	
2024-08-28	[Clinical Picture] Multimodality imaging of a large incidental papillary fibroelastoma	Wiaam Elkhatib, Prajwal Reddy	
2024-08-28	[Editorial] Legacies of conflict and humanitarian crises on cancer care	The Lancet Oncology	
2024-08-28	[Policy Review] Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup	Carien L Creutzberg, Jae-Weon Kim, Gemma Eminowicz, Emma Allanson, Lauriane Eberst, Se Ik Kim, Remi A Nout, Jeong-Yeol Park, Domenica Lorusso, Linda Mileshkin, Petronella B Ottevanger, Alison Brand, Delia Mezzanzanica, Amit Oza, Val Gebski, Bhavana Pothur	
2024-08-28	[Review] The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group	Philipp Karschnia, Jasper K W Gerritsen, Nico Teske, Daniel P Cahill, Asgeir S Jakola, Martin van den Bent, Michael Weller, Oliver Schnell, Einar O Vik-Mo, Niklas Thon, Arnaud J P E Vincent, Michelle M Kim, Guido Reifenberger, Susan M Chang, Shawn L Herve	
2024-08-28	[Correspondence] Enhancing cardiovascular disease risk management in childhood cancer survivors	Fei Liu, Qing Lan, Long Guo	
2024-08-28	[Corrections] Correction to Lancet Oncol 2023; 24: 733–43		
2024-08-28	[Correspondence] Enhancing equity and long-term impact assessments in radiotherapy environmental studies	Guang Yang, Jun Dou	
2024-08-28	[Correspondence] Enhancing cardiovascular disease risk management in childhood cancer survivors	Lan Yang, Jinlong Jiang, Shijie Guo	
2024-08-28	[Comment] Contextualising legal and ethical conundrums of artificial intelligence in oncology	Ghada Zakout	
2024-08-28	[Correspondence] Enhancing equity and long-term impact assessments in radiotherapy environmental studies	Xiang Li, Guo-Bao Huang	
2024-08-28	[Policy Review] Defining the quality of interdisciplinary care for patients with brain metastases: modified Delphi panel recommendations	Camilo E Fadul, Jason P Sheehan, Julio Silvestre, Gloribel Bonilla, Joseph A Bovi, Manmeet Ahluwalia, Riccardo Soffietti, David Hui, Roger T Anderson	
2024-08-28	[Policy Review] Translating the theranostic concept to neuro-oncology: disrupting barriers	Nathalie L Albert, Emilie Le Rhun, Giuseppe Minniti, Maximilian J Mair, Norbert Galldiks, Nelleke Tolboom, Asgeir S Jakola, Maximilian Niyazi, Marion Smits, Antoine Verger, Francesco Cicone, Michael Weller, Matthias Preusser, European Organisation for Res	
2024-08-28	[Personal View] Improving individualised therapies in localised gastro-oesophageal adenocarcinoma	Magali Svrcek, Thibault Voron, Thierry André, Elizabeth C Smyth, Christelle de la Fouchardière	
2024-08-28	[Articles] Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial	Mafalda Oliveira, Hope S Rugo, Sacha J Howell, Florence Dalenc, Javier Cortes, Henry L Gomez, Xichun Hu, Masakazu Toi, Komal Jhaveri, Petr Krivorotko, Sibylle Loibl, Serafin Morales Murillo, Meena Okera, Zbigniew Nowecki, Yeon Hee Park, Joo Hyuk Sohn, Eri	
2024-08-28	[News] Peru advances towards universal health care for patients with cancer	Talha Burki	
2024-08-28	[News] Progress in NCD screening in Mongolia	Sharmila Devi	
2024-08-28	[Perspectives] Ending financial discrimination for cancer survivors: embedding the Right to be Forgotten in legislation across Europe	Mark Lawler, Grazia Scocca, Françoise Meunier	
2024-08-28	[Articles] Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): long-term, health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial	Emanuel Bührer, Michal Kicinski, Mario Mandala, Madeline Pe, Georgina V Long, Victoria Atkinson, Christian U Blank, Andrew Haydon, Stéphane Dalle, Adnan Khattak, Matteo S Carlino, Andrey Meshcheryakov, Shahneen Sandhu, Susana Puig, Dirk Schadendorf, Rahim	
2024-08-28	[Comment] Measuring success of adjuvant treatment for patients with melanoma	Brent O'Carrigan, Pippa G Corrie	
2024-08-28	[Articles] Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7–IFCT-1402): a multicentre, randomised, controlled phas	Pierre Vera, Sébastien Thureau, Florence Le Tinier, Philippe Chaumet-Riffaud, Sébastien Hapdey, Hélène Kolesnikov-Gauthier, Etienne Martin, Alina Berriolo-Riedinger, Nicolas Pourel, Jean Marc Broglia, Pierre Boissellier, Sophie Guillemard, Naji Salem, Isa	
2024-08-28	[News] Disappointment facing patients with breast cancer as trastuzumab deruxtecan too expensive for NHS	Elizabeth Gourd	
2024-08-28	[Articles] Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): exploratory long-term follow-up of an open-label, multicentre, randomised, phase 3 trial	Jean-Yves Blay, Quentin Devin, Florence Duffaud, Maud Toulmonde, Nelly Firmin, Olivier Collard, Emmanuelle Bompas, Benjamin Verret, Isabelle Ray-Coquard, Sebastien Salas, Clemence Henon, Charles Honoré, Mehdi Brahmi, Armelle Dufresne, Marc Pracht, Alice H	
2024-08-28	[Articles] Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trial	Linda J Williams, Ian H Kunkler, Karen J Taylor, Joanna Dunlop, Tammy Piper, Jacqueline Caldwell, Wilma Jack, Joseph F Loane, Kenneth Elder, John M S Bartlett, J Michael Dixon, David A Cameron	
2024-08-28	[Comment] Who does not benefit from whole-breast radiotherapy and how to find them?	Hans-Christian Kolberg, Cornelia Kolberg-Liedtke	
2024-08-28	[Comment] Imatinib in advanced GIST: if it's working, don’t stop a good thing	Ryan A Denu, Neeta Somaiah	
2024-08-28	[Articles] Cancer incidence and survival for 11 cancers in the Commonwealth: a simulation-based modelling study	Zachary J Ward, Qassi Gaba, Rifat Atun	
2024-08-28	[Articles] Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial	Jana de Boniface, Matilda Appelgren, Robert Szulkin, Sara Alkner, Yvette Andersson, Leif Bergkvist, Jan Frisell, Oreste Davide Gentilini, Michalis Kontos, Thorsten Kühn, Dan Lundstedt, Birgitte Vrou Offersen, Roger Olofsson Bagge, Toralf Reimer, Malin Sun	
2024-08-28	[Comment] Time to abandon axillary lymph node dissection in early-stage breast cancer	Andrea V Barrio	
2024-08-28	[Articles] Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial	Kanwal Raghav, Salvatore Siena, Atsuo Takashima, Takeshi Kato, Marc Van den Eynde, Filippo Pietrantonio, Yoshito Komatsu, Hisato Kawakami, Marc Peeters, Thierry Andre, Sara Lonardi, Kensei Yamaguchi, Jeanne Tie, Cristina Gravalos Castro, Hung-Chih Hsu, Jo	
2024-08-28	[Comment] Trastuzumab deruxtecan in HER2-positive metastatic colorectal cancer: less is more?	Jeanine M L Roodhart, Miriam Koopman	
2024-08-28	[Articles] Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial	Nicoletta Colombo, Elena Biagioli, Kenichi Harano, Francesca Galli, Emma Hudson, Yoland Antill, Chel Hun Choi, Manuela Rabaglio, Frederic Marmé, Christian Marth, Gabriella Parma, Lorena Fariñas-Madrid, Shin Nishio, Karen Allan, Yeh Chen Lee, Elisa Piovano	
2024-08-28	[News] New immigration laws could undermine cancer research in the UK	Karl Gruber	
2024-08-28	[News] Poor progress on reducing alcohol consumption in Europe	Talha Burki	
2024-08-28	[Articles] Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study	Madeleine J Karpinski, Johannes Hüsing, Kevin Claassen, Lennart Möller, Hiltraud Kajüter, Florian Oesterling, Viktor Grünwald, Lale Umutlu, Jens Kleesiek, Tugce Telli, Anja Merkel-Jens, Anika Hüsing, Claudia Kesch, Ken Herrmann, Matthias Eiber, Sebastian	
2024-08-28	[Comment] Use of PROMISE criteria on PSMA-PET for prediction of overall survival in prostate cancer	Kirsten Bouchelouche, Peter L Choyke	
2024-08-28	[News] Improving cancer control initiatives in Indigenous people	Karl Gruber	
2024-08-28	[News] Over US$100 million pledged to improve cancer care across Africa	Paul Adepoju	
2024-07-30	[Clinical Picture] Primary cardiac angiosarcoma presenting as restrictive cardiomyopathy	Joshua M Peterson, Adam Gonzalez, Juan P Olano, Suimin Qiu, Tejo Musunuru, Kirill A Lyapichev	
2024-07-30	[Editorial] Incorporating whole-genome sequencing into cancer care	The Lancet Oncology	
2024-07-30	[Perspectives] Two-physician certification in end-of-life decision making	Abigail P Sneider, Valerie Gutmann Koch, Andrew Hantel, Peter Angelos	
2024-07-30	[Corrections] Correction to Lancet Oncol 2024; 25: e374–87		
2024-07-30	[Articles] Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial	Yi-Long Wu, Valentina Guarneri, Pei Jye Voon, Boon Khaw Lim, Jin-Ji Yang, Marie Wislez, Cheng Huang, Chong Kin Liam, Julien Mazieres, Lye Mun Tho, Hidetoshi Hayashi, Nguyen Viet Nhung, Puey Ling Chia, Filippo de Marinis, Jo Raskin, Qinghua Zhou, Giovanna	
2024-07-30	[Correspondence] Evaluating the KEYNOTE-057 trial's findings: addressing demographic, methodological, and economic considerations	Shen Wang	
2024-07-30	[Corrections] Correction to Lancet Oncol 2024; 25: e250–59		
2024-07-30	[Correspondence] Challenges and prospects for cancer treatment in prison settings	Feng Zhang	
2024-07-30	[Correspondence] Sotorasib versus docetaxel: evidence supporting CodeBreaK 200	Luis Paz-Ares, Bhakti Mehta, Yang Wang, David Waterhouse, Adrianus Johannes de Langen	
2024-07-30	[Review] Dose selection of novel anticancer drugs: exposing the gap between selected and required doses	Catharina J P Op ‘t Hoog, Niven Mehra, Marc Maliepaard, Kalijn Bol, Hans Gelderblom, Gabe S Sonke, Adrianus J de Langen, Niels W C J van de Donk, Jeroen J W M Janssen, Monique C Minnema, Nielka P van Erp, Emmy Boerrigter	
2024-07-30	[Correspondence] Challenges and prospects for cancer treatment in prison settings	Hujian Hong, Yanli Qu	
2024-07-30	[Review] Radiotherapy, immunity, and immune checkpoint inhibitors	Connor Lynch, Sean P Pitroda, Ralph R Weichselbaum	
2024-07-30	[Perspectives] Together and apart: experiences of childhood brain tumour	Kate Young, Christine Cashion, Natalie Bradford	
2024-07-30	[Comment] Molecular diagnosis and site-specific therapy in cancer of unknown primary: an important milestone	F Anthony Greco, Chris Labaki, Elie Rassy	
2024-07-30	[Articles] Site-specific therapy guided by a 90-gene expression assay versus empirical chemotherapy in patients with cancer of unknown primary (Fudan CUP-001): a randomised controlled trial	Xin Liu, Xiaowei Zhang, Shiyu Jiang, Miao Mo, Qifeng Wang, Yanli Wang, Liangping Zhou, Silong Hu, Huijuan Yang, Yifeng Hou, Yong Chen, Xueguan Lu, Yu Wang, Xiaoyan Zhou, Wentao Li, Cai Chang, Xiujiang Yang, Ke Chen, Jun Cao, Qinghua Xu, Yifeng Sun, Jianfe	
2024-07-30	[News] Lifestyle factors driving cancer cases and mortality in the USA	Karl Gruber	
2024-07-30	[News] Call for stricter tobacco control laws in Ghana	Manjulika Das	
2024-07-30	[News] Impact of pharmacy benefit managers on cancer health care	Priya Venkatesan	
2024-07-30	[Articles] Celiac plexus radiosurgery for pain management in advanced cancer: a multicentre, single-arm, phase 2 trial	Yaacov R Lawrence, Marcin Miszczyk, Laura A Dawson, Dayssy Alexandra Diaz Pardo, Artur Aguiar, Dror Limon, Raphael M Pfeffer, Michael Buckstein, Aisling S Barry, Tikva Meron, Adam P Dicker, Jerzy Wydmański, Camilla Zimmermann, Ofer Margalit, David Hausner	
2024-07-30	[Comment] Alleviating retroperitoneal pain with celiac plexus radiosurgery	Daniel Moore-Palhares, Sylvia S W Ng, Alexander V Louie	